摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5-dihydro-10-methoxy-5-oxo-2,2,4-trimethyl-1H-[1]benzopyrano [3,4-f]quinoline | 239070-97-4

中文名称
——
中文别名
——
英文名称
2,5-dihydro-10-methoxy-5-oxo-2,2,4-trimethyl-1H-[1]benzopyrano [3,4-f]quinoline
英文别名
10-methoxy-2,2,4-trimethyl-1,2-dihydro-5H-chromeno[3,4-f]quinolin-5-one;10-methoxy-2,2,4-trimethyl-1H-chromeno[3,4-f]quinolin-5-one
2,5-dihydro-10-methoxy-5-oxo-2,2,4-trimethyl-1H-[1]benzopyrano [3,4-f]quinoline化学式
CAS
239070-97-4
化学式
C20H19NO3
mdl
——
分子量
321.376
InChiKey
JEKNFUAVIRLIHF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    24
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    2,5-dihydro-10-methoxy-5-oxo-2,2,4-trimethyl-1H-[1]benzopyrano [3,4-f]quinoline二异丁基氢化铝 、 magnesium sulfate 作用下, 以 正己烷二氯甲烷 为溶剂, 反应 14.0h, 生成 5-(4-Chloro-phenoxy)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-6-oxa-1-aza-chrysene
    参考文献:
    名称:
    Synthesis and Characterization of Non-Steroidal Ligands for the Glucocorticoid Receptor:  Selective Quinoline Derivatives with Prednisolone-Equivalent Functional Activity
    摘要:
    A novel class of functional ligands for the human glucocorticoid receptor is described. Substituents in the C-10 position of the tetracyclic core are essential for glucocorticoid receptor (GR) selectivity versus other steroid receptors. The C-5 position is derivatized with meta-substituted aromatic groups, resulting in analogues with a high affinity for GR (K-i = 2.4-9.3 nM) and functional activity comparable to prednisolone in reporter gene assays of glucocorticoid-mediated gene transcription. The biological activity of these novel quinolines was also prednisolone-equivalent in whole cell assays of glucocorticoid function, and compound 13 was similar to prednisolone (po ED50 = 2.8 mpk for 13 vs ED50 = 1.2 mpk for prednisolone) in a rodent model of asthma (sephadex-induced eosinophil influx).
    DOI:
    10.1021/jm010228c
  • 作为产物:
    描述:
    2-溴-5-硝基苯甲酸甲酯 在 bis-triphenylphosphine-palladium(II) chloride 、 palladium on activated charcoal 氢气三溴化硼caesium carbonate 作用下, 以 1,4-二氧六环二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 136.0h, 生成 2,5-dihydro-10-methoxy-5-oxo-2,2,4-trimethyl-1H-[1]benzopyrano [3,4-f]quinoline
    参考文献:
    名称:
    Synthesis and Characterization of Non-Steroidal Ligands for the Glucocorticoid Receptor:  Selective Quinoline Derivatives with Prednisolone-Equivalent Functional Activity
    摘要:
    A novel class of functional ligands for the human glucocorticoid receptor is described. Substituents in the C-10 position of the tetracyclic core are essential for glucocorticoid receptor (GR) selectivity versus other steroid receptors. The C-5 position is derivatized with meta-substituted aromatic groups, resulting in analogues with a high affinity for GR (K-i = 2.4-9.3 nM) and functional activity comparable to prednisolone in reporter gene assays of glucocorticoid-mediated gene transcription. The biological activity of these novel quinolines was also prednisolone-equivalent in whole cell assays of glucocorticoid function, and compound 13 was similar to prednisolone (po ED50 = 2.8 mpk for 13 vs ED50 = 1.2 mpk for prednisolone) in a rodent model of asthma (sephadex-induced eosinophil influx).
    DOI:
    10.1021/jm010228c
点击查看最新优质反应信息

文献信息

  • Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
    申请人:Abbott Laboratories
    公开号:US06518430B1
    公开(公告)日:2003-02-11
    The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-f]quinolines.
    本发明涉及一种高效的制备5-(取代基)-10-甲氧基-2,2,4-三甲基-2,5-二氢-1H-咖啡因[3,4-f]喹啉的方法。
  • Asymmetric Synthesis of A-240610.0 via a New Atropselective Approach for Axially Chiral Biaryls with Chirality Transfer
    作者:Yi-Yin Ku、Tim Grieme、Prasad Raje、Padam Sharma、Steve A. King、Howard E. Morton
    DOI:10.1021/ja0171198
    日期:2002.4.1
    atropselective preparation of axially chiral biaryl was developed. This process proceeded through a chirality transfer from a stereogenic center of a secondary alcohol to the stereogenic axis via regioselective intramolecular silyl group migration. This methodology allowed for the preparation of a single atropisomer 2 in good yield (85%) with high diastereoselectivity (99:1), which subsequently led
    开发了一种用于轴向手性联芳基阻滞选择性制备的新方法。该过程通过区域选择性分子内甲硅烷基迁移,将手性从仲醇的立体中心转移到立体轴。这种方法允许以良好的收率 (85%) 制备具有高非对映选择性 (99:1) 的单一阻转异构体 2,随后成功开发了 A-240610.0, 1 的高效不对称合成。
  • Process for the preparation of 5-(substituted)-10 methoxy-2,2,4-trimethyl-2,5-dihydro- 1H-chromeno [3,4-f] quinolines and derivatives thereof
    申请人:——
    公开号:US20030069427A1
    公开(公告)日:2003-04-10
    The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-f]quinolines.
    本发明涉及一种高效的方法,用于制备5-(取代基)-10-甲氧基-2,2,4-三甲基-2,5-二氢-1H-色烯[3,4-f]喹啉。
  • Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity
    申请人:Matsuda Mamoru
    公开号:US20090326009A1
    公开(公告)日:2009-12-31
    An object of the present invention is to study synthesis of a novel 1,2-dihydroquinoline derivative and to find a pharmacological action of the derivative. A compound represented by the general formula (1) or a salt thereof is effective in the treatment of a glucocorticoid receptor-related disease. In the formula, the ring X represents a benzene ring or a pyridine ring; R 1 represents a halogen atom, an alkyl group, a hydroxy group, an alkoxy group, an amino group or the like; p represents an integer of 0 to 5; R 2 represents a halogen atom, an alkyl group, a hydroxy group or the like; q represents an integer of 0 to 2; R 3 represents a hydrogen atom, an alkyl group, an alkenyl group or the like; R 4 and R 5 represent a hydrogen atom or the like; R 6 represents a hydrogen atom or the like; A represents an alkylene group or the like; and R 7 represents OR 8 , NR 8 R 9 , SR 8 , S(O)R 8 or S(O) 2 R 8 , wherein R 8 represents an aryl group, a heterocyclic group or the like and R 9 represents a hydrogen atom or the like.
    本发明的目的是研究合成一种新型1,2-二氢喹啉衍生物,并发现该衍生物的药理作用。通式(1)表示的化合物或其盐在治疗糖皮质激素受体相关疾病方面具有有效性。在该式中,环X表示苯环或吡啶环;R1表示卤素原子、烷基、羟基、烷氧基、氨基或类似物;p表示0至5的整数;R2表示卤素原子、烷基、羟基或类似物;q表示0至2的整数;R3表示氢原子、烷基、烯基或类似物;R4和R5表示氢原子或类似物;R6表示氢原子或类似物;A表示烷基链或类似物;R7表示OR8、NR8R9、SR8、S(O)R8或S(O)2R8,其中R8表示芳基、杂环基或类似物,R9表示氢原子或类似物。
  • Process for the preparation of 5-(substituted)-10 methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno [3,4-F] quinolines and derivatives thereof
    申请人:——
    公开号:US06673930B2
    公开(公告)日:2004-01-06
    The present invention relates to an efficient process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-f]quinolines.
    本发明涉及一种高效的方法,用于制备5-(取代)-10-甲氧基-2,2,4-三甲基-2,5-二氢-1H-咔啉[3,4-f]喹啉。
查看更多